Strategic Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	$1.09M	Buy	14,360 +7,000	+95%	+$530K	0.54%	54
2021 Q3	$824K	Buy	+7,360	New	+$824K	0.43%	56